| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.967 | 0.004 | 0.969 | Cyclophilin D inhibitor | 0.969 0.004 DBMET00459 | DBMET00459 | |
| 0.946 | 0.001 | 0.96 | Dipeptidyl peptidase inhibitor | 0.96 0.001 DBMET00459 | DBMET00459 | |
| 0.94 | 0.001 | 0.954 | Dipeptidyl peptidase IV inhibitor | 0.954 0.001 DBMET00459 | DBMET00459 | |
| 0.687 | 0.012 | 0.687 | Antiobesity | 0.583 0.023 DBMET00459 | ||
| 0.662 | 0.001 | 0.662 | Dipeptidyl peptidase IX inhibitor | 0.652 0.001 DBMET00459 | ||
| 0.617 | 0.001 | 0.617 | Dipeptidyl peptidase VIII inhibitor | 0.609 0.001 DBMET00459 | ||
| 0.489 | 0.002 | 0.558 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.558 0.002 DBMET00459 | DBMET00459 | |
| 0.341 | 0.113 | 0.43 | Analgesic | 0.43 0.072 DBMET00459 | DBMET00459 | |
| 0.267 | 0.09 | 0.267 | Immunostimulant | 0.22 0.109 DBMET00459 | ||
| 0.159 | 0.003 | 0.159 | Prolyl endopeptidase inhibitor | 0.134 0.004 DBMET00459 | ||
| 0.159 | 0.012 | 0.159 | Acetylcholine release stimulant | 0.138 0.026 DBMET00459 | ||
| 0.142 | 0.018 | 0.142 | Opioid kappa receptor antagonist | 0.117 0.025 DBMET00459 | ||
| 0.236 | 0.123 | 0.236 | Ca(v)3.3 blocker | |||
| 0.115 | 0.004 | 0.115 | Prolactin release inhibitor | 0.115 0.004 DBMET00459 | ||
| 0.239 | 0.131 | 0.239 | Interleukin 2 agonist | 0.239 0.131 DBMET00459 | ||
| 0.111 | 0.003 | 0.111 | Dipeptidyl peptidase II inhibitor | 0.095 0.004 DBMET00459 | ||
| 0.131 | 0.032 | 0.131 | Opioid antagonist | 0.115 0.038 DBMET00459 | ||
| 0.173 | 0.078 | 0.173 | Lipocortins synthesis antagonist | 0.142 0.117 DBMET00459 | ||
| 0.054 | 0.004 | 0.054 | HCV NS5A inhibitor | 0.053 0.004 DBMET00459 | ||
| 0.085 | 0.038 | 0.085 | Opioid mu receptor antagonist | 0.074 0.043 DBMET00459 | ||
| 0.205 | 0.158 | 0.205 | Immunomodulator | |||
| 0.053 | 0.013 | 0.053 | Baculoviral IAP repeat-containing protein inhibitor | 0.053 0.014 DBMET00459 | ||
| 0.042 | 0.011 | 0.042 | Dipeptidyl peptidase I inhibitor | 0.037 0.014 DBMET00459 | ||
| 0.046 | 0.018 | 0.046 | Vascular adhesion protein 1 inhibitor | |||
| 0.063 | 0.044 | 0.063 | Opioid delta receptor antagonist | 0.055 0.05 DBMET00459 | ||
| 0.042 | 0.029 | 0.042 | Cholecystokinin antagonist | |||
| 0.021 | 0.008 | 0.021 | Complement factor D inhibitor | 0.018 0.012 DBMET00459 | ||
| 0.071 | 0.059 | 0.071 | Analgesic, opioid | |||
| 0.017 | 0.006 | 0.017 | Antibiotic Tetracycline-like | 0.015 0.011 DBMET00459 | ||
| 0.052 | 0.042 | 0.052 | Angiotensin-converting enzyme inhibitor | 0.051 0.044 DBMET00459 | ||
| 0.041 | 0.033 | 0.041 | Opioid kappa receptor agonist | 0.038 0.036 DBMET00459 | ||
| 0.042 | 0.038 | 0.042 | Opioid mu receptor agonist | |||
| 0.046 | 0.044 | 0.046 | Opioid agonist | |||
| 0.027 | 0.025 | 0.027 | Cholecystokinin B antagonist | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |